Cargando…

PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis

Bile acids play a pivotal role in the pathological development of inflammatory bowel disease (IBD). However, the mechanism of bile acid dysregulation in IBD remains unanswered. Here we show that intestinal peroxisome proliferator-activated receptor α (PPARα)-UDP-glucuronosyltransferases (UGTs) signa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xueyan, Cao, Lijuan, Jiang, Changtao, Xie, Yang, Cheng, Xuefang, Krausz, Kristopher W., Qi, Yunpeng, Sun, Lu, Shah, Yatrik M., Gonzalez, Frank J., Wang, Guangji, Hao, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164778/ https://www.ncbi.nlm.nih.gov/pubmed/25183423 http://dx.doi.org/10.1038/ncomms5573

Ejemplares similares

Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer
por: Cao, Lijuan, et al.
Publicado: (2017)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
por: Cui, Shuang, et al.
Publicado: (2023)

Feedback repression of PPARα signaling by Let-7 microRNA
por: Yagai, Tomoki, et al.
Publicado: (2021)

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Zhou, Jiyu, et al.
Publicado: (2020)

Lonicera Caerulea Juice Alleviates Alcoholic Liver Disease by Regulating Intestinal Flora and the FXR-FGF15 Signaling Pathway
por: Zhang, Baixi, et al.
Publicado: (2023)

Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis
por: Katafuchi, Takeshi, et al.
Publicado: (2022)

Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
por: He, Jinbiao, et al.
Publicado: (2022)

Reduction of p53 by Knockdown of the UGT1 Locus in Colon Epithelial Cells Causes an Increase in Tumorigenesis
por: Liu, Miao, et al.
Publicado: (2015)

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
por: He, Jinbiao, et al.
Publicado: (2023)

Chlorogenic Acid Inhibits Lipid Deposition by Regulating the Enterohepatic FXR-FGF15 Pathway
por: Ye, Xiaolin, et al.
Publicado: (2022)

Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
por: Carson, Matthew D., et al.
Publicado: (2023)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
por: Zhu, Ya-Di, et al.
Publicado: (2021)

Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR
por: Lee, Jae Man
Publicado: (2016)

Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
por: Byun, Sangwon, et al.
Publicado: (2018)

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
por: Bozadjieva, Nadejda, et al.
Publicado: (2018)

Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
por: Qiu, Yixuan, et al.
Publicado: (2021)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid/FXR-FGF15 in rats
por: Sun, Hanxiang, et al.
Publicado: (2023)

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
por: Cariello, Marica, et al.
Publicado: (2021)

Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis
por: Qiu, Han, et al.
Publicado: (2022)

Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity
por: Zhang, Youbo, et al.
Publicado: (2022)

Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate
Publicado: (1992)

Pharmacological Repression of PPARγ Promotes Osteogenesis
por: Marciano, David P., et al.
Publicado: (2015)

FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
por: van Golen, Rowan F., et al.
Publicado: (2018)

Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress
por: Cai, Weijia, et al.
Publicado: (2023)

Feedback regulation of cytoneme-mediated transport shapes a tissue-specific FGF morphogen gradient
por: Du, Lijuan, et al.
Publicado: (2018)

Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming
por: Xie, Yang, et al.
Publicado: (2016)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
por: Beuers, Ulrich, et al.
Publicado: (2022)

Reconstruction of FXR Beam Conditions
por: Nexsen, W E, et al.
Publicado: (2001)

UDP-Glucuronosyltransferase 1A Determinates Intracellular Accumulation and Anti-Cancer Effect of β-Lapachone in Human Colon Cancer Cells
por: Liu, Huiying, et al.
Publicado: (2015)

Role of PPARα and HNF4α in Stress-Mediated Alterations in Lipid Homeostasis
por: Konstandi, Maria, et al.
Publicado: (2013)

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015)

Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1
por: Pang, Juan, et al.
Publicado: (2023)

Activation of Pancreatic Acinar FXR Protects against Pancreatitis via Osgin1-Mediated Restoration of Efficient Autophagy
por: Zheng, Yufan, et al.
Publicado: (2022)

Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
Publicado: (2015)

Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
por: Ziros, Panos, et al.
Publicado: (2016)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
por: Maeda, Hiromichi, et al.
Publicado: (2014)

FXR controls CHOP expression in steatohepatitis
por: Fuchs, Claudia D., et al.
Publicado: (2017)

FXR expression in rats of hilar cholangiocarcinoma
por: Zhang, Meng-yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5rrp6728tslca657ikgcscod8h